156 related articles for article (PubMed ID: 30880271)
1. Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
Kang BH; Yu T; Kim JH; Park JM; Kim JI; Chung EJ; Kwon SK; Kim JH; Wu HG
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):104-109. PubMed ID: 30880271
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.
Sher DJ; Timmerman RD; Nedzi L; Ding C; Pham NL; Zhao B; Sumer BD
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):110-118. PubMed ID: 30880269
[TBL] [Abstract][Full Text] [Related]
3. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
Yu T; Wee CW; Choi N; Wu HG; Kang HC; Park JM; Kim JI; Kim JH; Kwon TK; Chung EJ
Laryngoscope; 2018 Nov; 128(11):2560-2565. PubMed ID: 29756264
[TBL] [Abstract][Full Text] [Related]
4. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?].
Tonneau M; Matta R; Lals S; Mirabel X; Crop F; Lacornerie T; Pasquier D; Escande A; Liem X
Cancer Radiother; 2021 Dec; 25(8):801-810. PubMed ID: 33931299
[TBL] [Abstract][Full Text] [Related]
6. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
7. A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.
Albuquerque K; Tumati V; Lea J; Ahn C; Richardson D; Miller D; Timmerman R
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):464-471. PubMed ID: 31697990
[TBL] [Abstract][Full Text] [Related]
8. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
10. Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy.
Spriano G; Antognoni P; Sanguineti G; Sormani M; Richetti A; Ameli F; Piantanida R; Luraghi R; Magli A; Corvo R; Tordiglione M; Vitale V
Am J Otolaryngol; 2000; 21(1):14-21. PubMed ID: 10668672
[TBL] [Abstract][Full Text] [Related]
11. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
12. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
13. The significance of arytenoid edema following radiotherapy of laryngeal carcinoma with respect to residual and recurrent tumour.
Ichimura K; Sugasawa M; Nibu K; Takasago E; Hasezawa K
Auris Nasus Larynx; 1997 Oct; 24(4):391-7. PubMed ID: 9352832
[TBL] [Abstract][Full Text] [Related]
14. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
15. Treatment of squamous cell carcinoma of the larynx by radiation.
Wang CC
Radiol Clin North Am; 1978 Aug; 16(2):209-18. PubMed ID: 704815
[No Abstract] [Full Text] [Related]
16. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
[TBL] [Abstract][Full Text] [Related]
17. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
[TBL] [Abstract][Full Text] [Related]
19. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
Wang CC; Nakfoor BM; Spiro IJ; Martins P
Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
[TBL] [Abstract][Full Text] [Related]
20. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]